Cafepharma Today

May 13 2025 - GSK axes $625M TIGIT drug as midphase data disappoint, promoting partner iTeos to cut costs
GSK axes $625M TIGIT drug as midphase data disappoint, promoting partner iTeos to cut costs
Elizabeth Holmes’s partner reportedly raises millions for blood-testing startup
Bluebird bio warns of potential bankruptcy after another buyout delay
HIV market expected to reach $32.1bn by 2033 in 7MM
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

[video] Johnson & Johnson Device Recall Unlikely to Affect Company Financials
TheStreet.com
Friday, August 1, 2014 - 9:05am
tags:
devices, Ethicon, recalls, laparoscopic power morcellators
As Valeant’s Stock Drops, So Does Its Takeover Price for Allergan
WSJ Online
Thursday, July 31, 2014 - 4:14pm
tags:
Valeant Pharmaceuticals, Allergan, M&A
FDA to begin overseeing growing field of medical tests developed by laboratories
Yahoo/AP
Thursday, July 31, 2014 - 4:08pm
tags:
FDA, diagnostics
FDA panel: Benefit of Baxter's immune therapy outweighs risk
Yahoo/Reuters
Thursday, July 31, 2014 - 4:03pm
tags:
FDA, advisory panels, Baxter International, HyQvia
FDA approves Boehringer's once-a-day inhaler drug
Yahoo/AP
Thursday, July 31, 2014 - 3:58pm
tags:
FDA, Boehringer Ingelheim, Striverdi Respimat, COPD
What's the gleam in Sanofi CEO's eye? Could be Q2--or a canny PCSK9 maneuver
Fierce Pharma
Thursday, July 31, 2014 - 11:54am
tags:
Chris Viehbacher, Sanofi, earnings, Pharma CEOs, PCSK9 inhibitors
Valeant says on hunt for more deals, including contact lenses
Yahoo/Reuters
Thursday, July 31, 2014 - 11:03am
tags:
Valeant Pharmaceuticals, M&A, contact lenses
Novartis apologizes for not disclosing side-effects of leukemia drugs sooner
Reuters
Thursday, July 31, 2014 - 11:01am
tags:
Novartis, side effects, Japan, leukemia
Does Valeant’s Cost-Cutting Go Too Far?
ProPublica
Thursday, July 31, 2014 - 10:59am
tags:
Valeant Pharmaceuticals
Gene therapy biotech Avalanche banks $102M in an up-sized IPO
Fierce Biotech
Thursday, July 31, 2014 - 10:04am
tags:
gene therapy, Avalanche Biotechnologies, IPOs
Former Lilly Scientists Fighting Wire Fraud Charges Battle Over Documents
WSJ Online
Thursday, July 31, 2014 - 10:00am
tags:
Eli Lilly, wire fraud, fraud, China
Flailing Dendreon Corporation (DNDN) Brings In Ex-Johnson & Johnson (JNJ) Exec For Top CEO Post
BioSpace
Thursday, July 31, 2014 - 9:42am
tags:
Dendreon, JNJ, Pharma CEOs, W. Thomas Amick
To Tweet or Not to Tweet? Or Even Retweet? FDA, Tweeting and Twitter
Eye on FDA
Thursday, July 31, 2014 - 9:34am
tags:
social media, FDA, twitter
Valeant Pharmaceuticals posts 12-fold rise in net profit
Yahoo/Reuters
Thursday, July 31, 2014 - 9:32am
tags:
earnings, Valeant Pharmaceuticals
Flu season should return Sanofi to double-digit vaccines growth, CEO says
Fierce Vaccines
Thursday, July 31, 2014 - 9:31am
tags:
Sanofi, Pharma CEOs, Chris Viehbacher, vaccines, Flu, flu vaccines
AstraZeneca steps up push into cancer immunotherapy
Yahoo/Reuters
Thursday, July 31, 2014 - 9:16am
tags:
cancer immunotherapy, AstraZeneca, MEDI4736
Endo raises forecast, reports better-than-expected profit
Yahoo/Reuters
Thursday, July 31, 2014 - 9:15am
tags:
earnings, Endo Health Solutions
Teva Quarterly Profit Rises on New Version of MS Drug
Bloomberg
Thursday, July 31, 2014 - 9:14am
tags:
Teva Pharmaceutical, earnings
Meda to Buy Rottapharm for $3.1 Billion to Add OTC Brands
Bloomberg
Thursday, July 31, 2014 - 9:13am
tags:
Meda, Rottapharm, M&A
Sanofi Raises Profit Forecast on Diabetes, Orphan Drugs
Bloomberg
Thursday, July 31, 2014 - 9:12am
tags:
earnings, Sanofi

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline
Treating Orthopox Viruses - With What?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.